Ticker

Analyst Price Targets — DOMA

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 15, 2022 5:42 amCitigroup$281.25$262.56Benzinga Citigroup Initiates Coverage On Doma Holdings with Neutral Rating, Announces Price Target of $0.45
August 10, 2022 10:08 amD.A. Davidson$1,562.50$475.00Benzinga DA Davidson Maintains Buy on Doma Holdings, Lowers Price Target to $2.5

Latest News for DOMA

DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

Pacira's Stock is Down 56% Over the Last Decade and Down 68% Over the Last 5 Years [i] ; Under the Leadership of CEO and Board Member Frank Lee, the Stock Has Fallen 30% [ii] ; The Company's Underperformance is Reflected in Consistently Missed Earnings, Continuous Lowering of Guidance, Which is Then Missed, and a Complete Lack of Combined Profitability in the Last Two Years [iii] ; We believe the Stock Price…

PRNewsWire • Mar 12, 2026
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

Pacira's Stock is Down 56% Over the Last Decade and Down 68% Over the Last 5 Years i ; Under the Leadership of CEO and Board Member Frank Lee, the Stock Has Fallen 30% ii ; The Company's Underperformance is Reflected in Consistently Missed Earnings, Continuous Lowering of Guidance, Which is Then Missed, and a Complete Lack of Combined Profitability in the Last Two Years iii ; We believe the Stock Price Reflects the…

PRNewsWire • Mar 11, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for DOMA.

No House trades found for DOMA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top